Athena Athena

X

Find Radio Compass News for Topiramate

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
173
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 100MG
  • TABLET;ORAL - 200MG
  • TABLET;ORAL - 25MG
  • TABLET;ORAL - 50MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 100MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 150MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 200MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 25MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 50MG

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-10-2024-93939.pdf

FDA
10 Jan 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217231

FDA
17 Nov 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215663

FDA
15 Aug 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205976

FDA
04 May 2023

https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-topiramate-extended-release-capsules-39359.pdf

FDA
21 Mar 2023

https://health.economictimes.indiatimes.com/news/pharma/zydus-launches-topiramate-extended-release-capsules-for-epilepsy/96788498

ECONOMICTIMES
06 Jan 2023

https://www.prnewswire.com/news-releases/qsymia-phentermine-topiramate-drug-insights-and-market-forecasts-to-2032-301712347.html

PR NEWSWIRE
03 Jan 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208949

FDA
28 Nov 2022

https://pink.pharmaintelligence.informa.com/PS146955/Use-of-Gynecological-Drugs-Restricted-In-EU-Urgent-Safety-Review-Starts-For-Pholcodine

Neena Brizmohun PINK SHEETS
05 Sep 2022

https://www.ema.europa.eu/en/news/prac-starts-review-topiramate-use-pregnancy-women-childbearing-potential

EMA
02 Sep 2022

https://endpts.com/icer-reaffirms-qsymia-as-most-cost-effective-obesity-treatment-in-final-report/

Paul Schloesser ENDPTS
31 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215638

FDA
29 Jul 2022

https://www.medscape.com/viewarticle/976307

Miriam E. Tucker MEDSCAPE
29 Jun 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215663

FDA
09 Jun 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-1-2021-1638337020.pdf

FDA
01 Dec 2021

https://www.europeanpharmaceuticalreview.com/news/165242/aimovigdisplays-superiority-over-topiramate-in-migraine-study/

Anna Begley EUROPEANPHARMACEUTICALREVIEW
09 Nov 2021

https://www.pharmaceutical-technology.com/news/fda-eton-azurity-eprontia-seizures/

PHARMACEUTICAL-TECHNOLOGY
09 Nov 2021

https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-inc-announces-fda-approval-of-eprontia-topiramate-oral-solution-301417993.html

PRNEWSWIRE
08 Nov 2021

https://www.globenewswire.com/news-release/2021/11/08/2329012/0/en/Eton-Pharmaceuticals-and-Azurity-Pharmaceuticals-Inc-Announce-FDA-Approval-of-EPRONTIA-topiramate-Oral-Solution.html

GLOBENEWSWIRE
08 Nov 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215414

FDA
26 Aug 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210278

FDA
06 Feb 2021

https://www.prnewswire.com/in/news-releases/glenmark-pharmaceuticals-receives-anda-approval-for-topiramate-extended-release-capsules-25-mg-50-mg-100-mg-150-mg-and-200-mg-859397600.html

PRNEWSWIRE
03 Feb 2021

https://www.nasdaq.com/press-release/eton-pharmaceuticals-announces-acceptance-for-filing-of-new-drug-application-for-1

NASDAQ
17 Dec 2020

https://www.nasdaq.com/press-release/eton-pharmaceuticals-announces-acceptance-for-filing-of-new-drug-application-for-1

NASDAQ
17 Dec 2020

https://pharmaphorum.com/news/novartis-aimovig-tops-topiramate-in-migraine-face-off/?utm_source=pharmaphorum+Daily+Newsletter&utm_campaign=c8ccf15e4e-EMAIL_CAMPAIGN_2019_09_24_10_10_COPY_01&utm_medium=email&utm_term=0_a54496134b-c8ccf15e4e-443826894

Phil Taylor PHARMAPHORUM
05 Nov 2020

https://www.businesswire.com/news/home/20200317005313/en

BUSINESSWIRE
17 Mar 2020

https://www.globenewswire.com/news-release/2020/03/17/2001825/0/en/Eton-Pharmaceuticals-Reports-Positive-Study-Results-for-ET-101-Topiramate-Oral-Solution.html

GLOBE NEWSWIRE
17 Mar 2020

https://www.fiercebiotech.com/research/fighting-obesity-by-attacking-both-food-intake-and-energy-burn?utm_source=internal&utm_medium=rss

Arlene Weintraub FIERCE BIOTECH
29 Jun 2019

https://www.fiercepharma.com/marketing/prescription-drug-police-ding-vivus-for-misleading-qsymia-obesity-treatment-webpage

Beth S. Bulik FIERCE PHARMA
07 Jun 2019

https://www.raps.org/news-and-articles/news-articles/2019/5/opdp-issues-second-untitled-letter-of-2019

Michael Mezher RAPS
30 May 2019

https://www.business-standard.com/article/companies/glenmark-pharma-gets-usfda-nod-for-seizure-treatment-drug-119012400247_1.html

BUSINESSWIRE
25 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210278

FDA
22 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205976

FDA
25 Sep 2018

https://www.biospace.com/article/supernus-pharma-to-buy-biscayne-neurotherapeutics-in-potential-183-million-deal-am6a-/?s=79

Mark Terry BIOSPACE
15 Sep 2018

https://endpts.com/a-new-avenue-for-diet-pill-makers-uc-san-diego-researchers-uncover-root-of-leptin-resistance/

Brittany Meiling ENDPTS
24 Aug 2018

https://endpts.com/with-debt-looming-browbeaten-diet-pill-maker-orexigen-goes-bankrupt/

B. Meiling ENDPTS
13 Mar 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207382

FDA
29 Nov 2017

http://www.pharmatimes.com/news/new_migraine_results_for_both_allergen_and_novartis_1204968

George Underwood PHARMA TIMES
11 Sep 2017

http://www.prnewswire.com/news-releases/upsher-smith-launches-newly-designed-website-for-qudexy-xr-topiramate-extended-release-capsules-300506940.html

PR NEWSWIRE
22 Aug 2017

http://www.prnewswire.com/news-releases/fda-approves-expanded-indication-for-qudexy-xr-topiramate-extended-release-capsules-to-include-prophylaxis-of-migraine-headache-in-adults-and-adolescents-300431866.html

PR NEWSWIRE
30 Mar 2017

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cadila-inks-pact-with-supernus-pharma-to-settle-patent-issue/articleshow/57512394.cms

ECONOMIC TIMES
08 Mar 2017

https://www.pharma-excipients.ch/2017/03/08/topiramate-extended-release-options-a-focus-onefficacy-and-safety-in-epilepsy-and-comorbidities/

PHARMA-EXCIPIENTS
07 Mar 2017

https://globenewswire.com/news-release/2016/12/12/897034/0/en/Supernus-Wins-Appeal-Case-on-Oxtellar-XR.html

GLOBENEWSWIRE
12 Dec 2016

http://www.pharma-excipients.ch/2016/11/08/trial-of-amitriptyline-topiramate-and-placebo-for-pediatric-migraine/

PHARMA EXCIPIENTS
08 Nov 2016

http://www.prnewswire.com/news-releases/upsher-smith-launches-its-that-simple-program-for-qudexy-xr-topiramate-extended-release-capsules-300324281.html

PR NEWSWIRE
08 Sep 2016

http://www.prnewswire.com/news-releases/upsher-smith-granted-tentative-fda-approval-for-qudexy-xr-topiramate-extended-release-capsules-for-prophylaxis-of-migraine-headache-in-adults-300282668.html

PR NEWSWIRE
09 Jun 2016

http://cphi-online.com/future-obesity-drugs-must-provide-improved-news038407.html

CPHI-ONLINE
17 Dec 2015

http://www.fiercepharma.com/story/vivus-counts-25m-q3-sales-300m-debt-how-can-it-possibly-cover-200m-plus-qsy/2015-11-05

Carly Helfand FIERCE PHARMA
05 Nov 2015

http://www.fiercepharma.com/story/icahn-casts-his-eye-vivus-tender-offer-convertible-notes/2015-09-09

Carly Helfand FIERCE PHARMA
09 Sep 2015

http://www.fiercepharmamarketing.com/story/brutal-honesty-drug-marketing-obesity-meds-its-key-avoiding-magic-pill-trap/2015-06-08

Beth Snyder Bulik FIERCE PHARMA MARKETING
09 Jun 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY